Conditions: Diabetic Neuropathy, Painful
Keywords: Diabetic Peripheral Neuropathy
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 237
Healthy volunteers: no

Brief summary:
The purpose of the study is to learn if long-term treatment with DVS SR is safe for treating the pain and other symptoms associated with diabetic peripheral neuropathy.

Detailed description:

Arms:
arm 1: Daily dose of 100mg or 200mg at the investigators discretion. Subjects already randomized at a dose of 400mg may continue at that dose level.

Interventions: intervention 1: Desvenlafaxine Succinate Sustained-Release (DVS SR)
Intervention descriptions: intervention 1: None

Protocol document: